Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Molecular Pharmacology|July 29, 2005
Heterogeneity and selective targeting of neuronal nicotinic acetylcholine receptor (nAChR) subtypes expressed on retinal afferents of the superior colliculus and lateral geniculate nucleus: identification of a new native nAChR subtype alpha3beta2(alpha5 or beta3) enriched in retinocollicular afferentsCecilia Gotti, Milena Moretti, Alessio Zanardi, et al.
Nanomedicine (London, England)|June 18, 2015
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targetingYuliana Monsalve, Giovanni Tosi, Barbara Ruozi, et al.
Neuroendocrinology|March 8, 2003
Ontogeny and tissue-specific regulation of ghrelin mRNA expression suggest that ghrelin is primarily involved in the control of extraendocrine functions in the ratAntonio Torsello, Barbara Scibona, Giuseppina Leo, et al.
Journal of Neurochemistry|May 15, 2026
Unveiling the Molecular Mechanism of Intestinal Metabolite para-Cresol in Modulating Neuroinflammation and Synaptic Dysfunction: Implications for Autism Spectrum DisorderWenjie Liao, Kristy Antonioni, Federica Silvestri, et al.
Synapse (New York, N.Y.)|October 9, 2004
Alteration of hippocampal cell proliferation in mice lacking the beta 2 subunit of the neuronal nicotinic acetylcholine receptorAlexia Harrist, Robert D Beech, Sarah L King, et al.
European Journal of Medicinal Chemistry|July 13, 2015
Bifunctional compounds targeting both D2 and non-α7 nACh receptors: design, synthesis and pharmacological characterizationCarlo Matera, Luca Pucci, Chiara Fiorentini, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 2, 2020
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidenceJason T Duskey, Ilaria Ottonelli, Federica Da Ros, et al.
Biochemical Pharmacology|February 18, 2019
The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neuronsCarlo Matera, Federica Bono, Silvia Pelucchi, et al.
European Journal of Human Genetics : EJHG|August 10, 2018
Genetic variation in CHRNA7 and CHRFAM7A is associated with nicotine dependence and response to varenicline treatmentCinzia Cameli, Elena Bacchelli, Maria De Paola, et al.
Pathogens (Basel, Switzerland)|May 27, 2023
Hydroxypropyl-β-Cyclodextrin Depletes Membrane Cholesterol and Inhibits SARS-CoV-2 Entry into HEK293T-ACE<sup>hi</sup> CellsSilvia Alboni, Valentina Secco, Bianca Papotti, et al.
Pageof 12